MedTrace Logo

Epidemiological Study to Describe Non Small Cell Lung Cancer Clinical Management Patterns in MENA. Lung-EPICLIN/ Gulf

NCT01562665 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2016-05-24

No results posted yet for this study

Summary

The overall aim of the study is:

To provide accurate and reliable information regarding NSCLC clinical management across MENA region in order to detect unmet medical needs of this disease in terms of:

* Patient and hospital characteristics.
* Diagnostic and treatment approaches: initial and subsequent.
* Follow-up patterns in clinical management.
* Outcomes: symptoms, death, functionality, quality of life.
* Use of resources and burden on patients and health care systems.

Conditions

  • Non Small Cells Lung Cancer

Sponsors & Collaborators

Principal Investigators

  • Kakil Rasul, CONSULTANT · Hamad Medical Corporation, Doha, Qatar

  • Ahmed El Khodary, CONSULTANT · Kuwait Cancer Centre, Al Sabah Hospital, Kuwait

  • Norbert Drier, CONSULTANT · Zayed Military Hospital, Abu Dhabi, United Arab Emirates

  • Farid Khalifa, CONSULTANT · Salmaniya Medical Complex, Bahrain

  • Mohamed Jaloudy, CONSULTANT · Tawam Hospital ,Alain,Abu Dhabi, United Arab Emirates

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • Bahrain
  • Qatar
  • United Arab Emirates

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01562665 on ClinicalTrials.gov